Structure | Chemical Name | CAS | MF |
|
N-METHYL-N-[(6-MORPHOLIN-4-YLPYRIDIN-2-YL)METHYL]AMINE
|
886851-30-5
|
C11H17N3O
|
|
N-METHYL-4-(1,3-THIAZOL-2-YL)BENZYLAMINE
|
886851-31-6
|
C11H12N2S
|
|
1H-Benzimidazole-6-methanamine, N-methyl-
|
886851-32-7
|
C9H11N3
|
|
[3-(2-FURYL)-1-METHYL-1H-PYRAZOL-5-YL]METHANOL
|
886851-33-8
|
C9H10N2O2
|
|
3-THIEN-3-YLBENZOYL CHLORIDE
|
886851-34-9
|
C11H7ClOS
|
|
(2-Thiomorpholinopyrid-4-yl)methylamine
|
886851-35-0
|
C10H15N3S
|
|
2-(2-DIMETHYLAMINOETHOXY)-BROMOBENZENE
|
886851-37-2
|
C10H14BrNO
|
|
N,N-DIMETHYL-2-[4-[(METHYLAMINO)METHYL]PHENOXY]ETHANAMINE
|
886851-38-3
|
C12H20N2O
|
|
4-(4-Nitrophenoxy)tetrahydro-2H-pyran
|
886851-40-7
|
C11H13NO4
|
|
N-Methyl-(6-thien-2-ylpyrid-3-yl)methylamine
|
886851-41-8
|
C11H12N2S
|
|
6-(2-FURYL)NICOTINALDEHYDE
|
886851-42-9
|
C10H7NO2
|
|
N-METHYL-[6-(2-FURYL)PYRID-3-YL]METHYLAMINE
|
886851-44-1
|
C11H12N2O
|
|
5-(2-FURYL)PYRIDINE-2-CARBALDEHYDE
|
886851-45-2
|
C10H7NO2
|
|
n-methyl-4-pyrimidin-2-ylbenzylamine
|
886851-48-5
|
C12H13N3
|
|
n-methyl-3-pyrimidin-2-ylbenzylamine
|
886851-49-6
|
C12H13N3
|
|
2-MORPHOLINO-5-(TRIFLUOROMETHYL)BENZALDEHYDE
|
886851-50-9
|
C12H12F3NO2
|
|
[2-MORPHOLINO-5-(TRIFLUOROMETHYL)PHENYL]METHANOL
|
886851-51-0
|
C12H14F3NO2
|
|
N-METHYL-2-MORPHOLINO-5-(TRIFLUOROMETHYL)BENZYLAMINE
|
886851-52-1
|
C13H17F3N2O
|
|
7-BROMO-2,3-DIHYDROTHIENO[3,4-B][1,4]DIOXINE-5-CARBONYL CHLORIDE 90
|
886851-53-2
|
C7H4BrClO3S
|
|
N-METHYL-5-(AMINOMETHYL)-7-BROMO-2,3-DIHYDROTHIENO[3,4-B][1,4]DIOXINE 97
|
886851-54-3
|
C8H10BrNO2S
|
|
6-(tetrahydropyran-4-yloxy)nicotinic acid
|
886851-55-4
|
C11H13NO4
|
|
5-(Hydroxymethyl)-4-methyl-2-pyridin-4-yl-1,3-thiazole
|
886851-57-6
|
C10H10N2OS
|
|
1-(6-METHYLPYRAZIN-2-YL)PIPERIDINE-4-CARBOXYLIC ACID
|
886851-58-7
|
C11H15N3O2
|
|
[1-(6-Methylpyrazin-2-yl)piperid-4-yl]methanol
|
886851-59-8
|
C11H17N3O
|
|
Ethyl 1-(6-methylpyrazin-2-yl)piperidine-4-carboxylate
|
886851-60-1
|
C13H19N3O2
|
|
3-(1,3-DIOXOLAN-2-YL)FURAN-2-SULFONYL CHLORIDE
|
886851-63-4
|
C7H7ClO5S
|
|
1-METHYL-3-(3-NITROPHENYL)PYRAZOLE
|
886851-64-5
|
C10H9N3O2
|
|
[2-(MORPHOLIN-4-YLMETHYL)-1H-BENZIMIDAZOL-1-YL]ACETIC ACID
|
886851-65-6
|
C14H17N3O3
|
|
3-AMINO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE 97
|
886851-66-7
|
C5H7N3O
|
|
Methyl 3-N,N-dimethylamino-2-formylacrylate
|
886851-67-8
|
C7H11NO3
|
|
4-(3-HYDROXYPHENYL)-1,4-DIAZEPANE, N1-BOC PROTECTED 95%TERT-BUTYL 4-(3-HYDROXYPHENYL)PERHYDRO-1,4-DIAZEPINE-1-CARBOXYLATE
|
886851-68-9
|
C16H24N2O3
|
|
2-Methoxyquinoline-3-boronic acid
|
886853-93-6
|
C10H10BNO3
|
|
2-AMINO-5-IODOPYRAZINE
|
886860-50-0
|
C4H4IN3
|
|
Heterotaxin
|
886862-25-5
|
C12H19NO
|
|
2-PIPERIDIN-4-YLMETHYLPYRIDINE 2HCL
|
886886-02-8
|
C11H18Cl2N2
|
|
3-METHYL-5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE
|
886886-04-0
|
C6H10N4
|
|
Methyl 2-chloro-5-phenylbenzoate
|
886969-94-4
|
C14H11ClO2
|
|
5-METHYLPYRIDIN-2-YLAMINE
|
886970-76-9
|
C6H8N2
|
|
5,5,8,8-tetramethyl-3-(6-(6-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydrobenzo[e][1,2,4]triazin-3-yl)pyridin-2-yl)pyridin-2-yl)-5,6,7,8-tetrahydrobenzo[e][1,2,4]triazine
|
886970-80-5
|
C32H38N8
|
|
Boronic acid, [2,3-dihydro-8-[(1-oxo-2-propenyl)amino]-1,4-benzodioxin-6-yl]- (9CI)
|
886974-25-0
|
C11H12BNO5
|
|
2-PyrazinecarboxaMide, N-[(1S)-2-[[(1R)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]-
|
886979-78-8
|
C19H24N4O4
|
|
2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]-
|
886979-81-3
|
C19H24N4O4
|
|
2(3H)-Benzofuranone, 5-fluoro-
|
886985-48-4
|
C8H5FO2
|
|
Benzoic acid, 2-[(1E)-2-iodoethenyl]-, methyl ester
|
886986-52-3
|
C10H9IO2
|
|
8,8,8-TRIFLUORO-7-TRIFLUOROMETHYL-OCTANE-1,7-DIOL
|
886989-80-6
|
C9H14F6O2
|
|
Piperlotine C
|
886989-88-4
|
C16H21NO4
|
|
Neobritannilactone B
|
886990-00-7
|
C15H20O3
|
|
Ac-Gly-BoroPro
|
886992-99-0
|
C8H15BN2O4
|
|
AC-GLY-PRO-AFC
|
886993-02-8
|
C19H18F3N3O5
|
|
(6,7-Dimethoxy-1,2,3,4-tetrahydro-isoquinolin-3-yl)-methanol hydrochloride
|
886997-74-6
|
C12H18ClNO3
|
|
N-Trityl Candesartan Cilexetil
|
886999-34-4
|
C52H48N6O6
|
|
N-Triphenylmethyl Irbesartan
|
886999-35-5
|
C44H42N6O
|
|
Propanedinitrile,2-(4-oxo-3-
phenyl-2-selenazolidinylidene)-
|
887000-70-6
|
C12H7N3OSe
|
|
Rizatriptan EP Impurity A
|
887001-08-3
|
C28H35N7
|
|
CHEMBRDG-BB 4009812
|
887029-37-0
|
C12H18N2O
|
|
[2-(1-PIPERAZINYLMETHYL)CYCLOHEXYL]METHANOL
|
887029-38-1
|
C12H24N2O
|
|
3-BROMO-4-(TETRAHYDRO-2-FURANYLMETHOXY)-BENZOIC ACID
|
887029-50-7
|
C12H13BrO4
|
|
2-METHOXYPROPANOHYDRAZIDE
|
887029-63-2
|
C4H10N2O2
|
|
2-[2-(SEC-BUTYL)PHENOXY]PROPANOIC ACID
|
887029-70-1
|
C13H18O3
|
|
[2-(PIPERIDIN-1-YLMETHYL)-1H-BENZIMIDAZOL-1-YL]ACETIC ACID
|
887032-04-4
|
C15H19N3O2
|
|
1-(4-Fluorophenyl)-5-methyl-1,2,3-triazole-4-carboxylic Acid
|
887035-89-4
|
C10H8FN3O2
|
|
(4-Isopropyl-6-oxo-1,6-dihydro-pyrimidin-2-ylsulfanyl)-acetic acid
|
887040-49-5
|
C9H12N2O3S
|
|
[(PYRIDIN-3-YLMETHYL)THIO]ACETIC ACID
|
887090-42-8
|
C8H9NO2S
|
|
Thioacetic acid S-(2-cyano-benzyl) ester
|
887092-54-8
|
C10H9NOS
|
|
S-2-Chlorobenzyl Ethanethioate
|
887092-71-9
|
C9H9ClOS
|
|
2-[2-(DiphenylMethyl)-1-azabicyclo[2.2.2]oct-3-ylidene]-1-(2-Methoxyphenyl)-ethanone
|
887109-77-5
|
C29H29NO2
|
|
1-(4-Fluorobenzyl)-5-nitro-1H-indazole
|
887114-51-4
|
C14H10FN3O2
|
|
1-BENZENESULFONYL-3-IODO-1H-PYRROLO[2,3-B]PYRIDINE
|
887115-53-9
|
C13H9IN2O2S
|
|
5-Bromo-1-methyl-1H-pyrazolo[3,4-b]pyridine
|
887115-56-2
|
C7H6BrN3
|
|
2,7-DIAZASPIRO[4.5]DECAN-1-ONE
|
887118-43-6
|
C8H14N2O
|
|
tert-butyl 2,4-dioxo-1,3,7-triazaspiro[4.5]decane-7-carboxylate
|
887120-96-9
|
C12H19N3O4
|
|
1H-Indene-2-carboxylic acid, 1-aMino-2,3-dihydro-
|
887127-22-2
|
C10H11NO2
|
|
3,6-Dibromo-2,7-diiodo-phenanthrene-9,10-dione
|
887127-69-7
|
C14H4Br2I2O2
|
|
2-chloro-4-(1,1-dioxothiazinan-2-yl)benzoic acid
|
887129-69-3
|
C11H12ClNO4S
|
|
6α-BroMobecloMetasone Dipropionate
|
887130-69-0
|
C28H36BrClO7
|
|
2-(2,4-Difluoro-phenyl)-1-[(4-iodo-benzyl)-methyl-amino]-3-[1,2,4]triazol-1-yl-propan-2-ol
|
887138-63-8
|
C19H19F2IN4O
|
|
1-(4-broMo-2-fluorophenyl)-N-MethylMethanaMine
|
887139-06-2
|
C8H9BrFN
|
|
(4-Iodobenzyl)methylamine
|
887139-07-3
|
C8H10IN
|
|
(R)-2,2-diMethyl-10-(((3-nitropyridin-2-yl)disulfanyl)Methyl)-4,8-dioxo-3,6-dioxa-5,9-diazaundecan-11-oic acid
|
887140-25-2
|
C15H20N4O8S2
|
|
Palmitoyl Tetrapeptide-10
|
887140-79-6
|
C41H72N6O7
|
|
Phenol, 2-amino-5-propyl-
|
887141-18-6
|
C9H13NO
|
|
Butanedioic acid, bromo-, 4-(1,1-dimethylethyl) 1-methyl ester, (2S)- (9CI)
|
887143-08-0
|
C9H15BrO4
|
|
N-(1-(5-Bromo-3-fluoropyridin-2-yl)vinyl)acetamide
|
887143-43-3
|
C9H8BrFN2O
|
|
1-TrifluoroMethyl-1,2-benziodoxol-3(1H)-one
|
887144-94-7
|
C8H4F3IO2
|
|
1,3-Dihydro-3,3-dimethyl-1-(trifluoromethyl)-1,2-benziodoxole, Tognis Reagent
|
887144-97-0
|
C10H10F3IO
|
|
2-(5-Chloro-1H-indazol-3-yl)-acetamide
|
887145-79-1
|
C9H8ClN3O
|
|
4,6-dichloro-1-Methyl-1H-iMidazo[4,5-c]pyridine
|
887147-19-5
|
C7H5Cl2N3
|
|
2,6-dichloro-N-Methyl-3-nitropyridin-4-aMine
|
887147-20-8
|
C6H5Cl2N3O2
|
|
1α-Hydroxytorilin
|
887147-75-3
|
C22H32O6
|
|
BenzaMide, N-[(1S)-1-cyano-2-[5-cyano-2-(trifluoroMethyl)phenoxy]-1-Methylethyl]-4-[(trifluoroMethyl)thio]-
|
887148-69-8
|
C20H13F6N3O2S
|
|
Atorvastatin EP IMpurity F
|
887196-24-9
|
C40H48FN3O8
|
|
3S,5R isoMer, or (3S,5R)-7-[3-(phenylcarbaMoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calciuM salt
|
887196-25-0
|
C33H34CaFN2O5+
|
|
O-Methyl Atorvastatin Calcium Salt
|
887196-29-4
|
C67H68Ca2F2N4O10
|
|
3-Oxo Atorvastatin
|
887196-30-7
|
C33H33FN2O5
|
|
2-(2-METHYLPHENYL)-2,6-DIHYDRO-4H-THIENO[3,4-C]PYRAZOL-3-AMINE
|
887200-93-3
|
C12H13N3S
|
|
5-(1,3-THIAZOL-2-YL)THIOPHENE-2-CARBOXYLIC ACID
|
887201-16-3
|
C8H5NO2S2
|
|
1-(4-ETHOXYPHENYL)-1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE
|
887201-27-6
|
C15H18N2O
|
|
1-(4-pyridinyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine(SALTDATA: FREE)
|
887201-29-8
|
C12H13N3
|
|
5-(6-HYDROXY-5-METHYL-PYRIDIN-3-YL)-THIOPHENE-2-CARBOXYLIC ACID
|
887201-37-8
|
C11H9NO3S
|
|
4-CHLORO-7-(3-CHLORO-4-METHYLPHENYL)-5-PHENYL-7H-PYRROLO[2,3-D]PYRIMIDINE
|
887202-25-7
|
C19H13Cl2N3
|